American Society of Hematology

SHERPA: Blue

People

  1. Zhang
    Zhang
  2. Dogan
    Dogan
  3. Roshal
    Roshal
  4. Tallman
    Tallman
  5. Levine
    Levine
  6. Xiao
    Xiao
  7. Arcila
    Arcila
  8. Lesokhin
    Lesokhin
  9. Maclachlan
    Maclachlan
  10. Derkach
    Derkach

Groups

  1. Department of Pathology and Laboratory Medicine (53)
  2. Center for Hematologic Malignancies (49)
  3. Department of Medicine (48)
  4. Hematologic Malignancies, Division of (47)
  5. Adult Leukemia (30)
  6. Sloan Kettering Institute Postdocs (26)
  7. Executive Committee, Center for Hematologic Malignancies (24)
  8. Epidemiology and Biostatistics (23)
  9. GSK Faculty (22)
  10. Graduate Medical Education (20)
Search Within
  1. "Yanming Zhang"
Formats
  1. Meeting Abstract (37)
  2. Journal Article (16)
Groups
  1. Department of Pathology and Laboratory Medicine (53)
  2. Center for Hematologic Malignancies (49)
  3. Department of Medicine (48)
  4. Hematologic Malignancies, Division of (47)
  5. Adult Leukemia (30)
  6. Sloan Kettering Institute Postdocs (26)

More Groups

People
  1. Yanming Zhang (53)
  2. Ahmet Dogan (19)
  3. Martin Tallman (18)
  4. Mikhail Roshal (18)
  5. Kylee Maclachlan (17)
  6. Ross Levine (17)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (10)
  4. 2022 (11)
  5. 2021 (5)
  6. 2020 (9)

More Years

Publications
  1. Blood (42)
  2. Blood Advances (11)

Results (53)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Defining 2 biologically and clinically distinct groups in acute leukemia with a mixed phenotype
    Journal Article

    Galera, P.; Dilip, D.; Derkach, A.; Chan, A.; Zhang, Y.; Persaud, S.; Mishra, T.; Kramer, K.; Kathpalia, M.; Liu, Y.; more...
    Blood (2025)

    Fulltext@MSK | Save
  • Genomic complexity correlates with the degree of marrow independence of malignant plasma cells in the context of extramedullary disease
    Meeting Abstract

    Maclachlan, K. H.; Garces, J. J.; Shekarkhand, T.; Rajeeve, S.; Hashmi, H.; Hassoun, H.; Hultcrantz, M.; Korde, N.; Tan, C. R.; Mailankody, S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • The biological and clinical impact of deletions before and after large chromosomal gains in multiple myeloma
    Journal Article

    Cirrincione, A. M.; Poos, A. M.; Ziccheddu, B.; Kaddoura, M.; Bärtsch, M. A.; Maclachlan, K.; Chojnacka, M.; Diamond, B.; John, L.; Reichert, P.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Assessment of outcomes of consolidation therapy by number of cycles of blinatumomab received in newly diagnosed measurable residual disease negative patients with B-lineage acute lymphoblastic leukemia: In the ECOG-ACRIN E1910 Randomized Phase III National Clinical Trials Network Trial
    Meeting Abstract

    Luger, S. M.; Sun, Z.; Mattison, R. J.; Paietta, E.; Roberts, K. G.; Zhang, Y.; Racevckis, J.; Lazarus, H. M.; Rowe, J. M.; Arber, D. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A pro-inflammatory gene signature characterizes a better risk aged AML patient group in ECOG-ACRIN Cancer Research Group's clinical trial E3999
    Meeting Abstract

    Neelamraju, Y.; Rapaport, F.; Gandara, J. A.; Dunham, N.; Fan, H.; Lee, T.; Prajapati, S.; Sheridan, C.; Wang, L.; Cripe, L. D.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Comprehensive genomic characterization of response and resistance to daratumumab-based quadruplet induction in newly diagnosed multiple myeloma patients
    Meeting Abstract

    Maclachlan, K. H.; Tan, C. R.; Shekarkhand, T.; Rueda, C.; Serrano, E.; Nemirovsky, D.; Derkach, A.; McPherson, A.; Diamond, B.; Ziccheddu, B.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • The complex structural variant chromothripsis can be defined on targeted sequencing panels, allowing direct clinical translation in order to improve multiple myeloma prognostication
    Meeting Abstract

    Maclachlan, K. H.; Ziccheddu, B.; Tan, C.; Shekarkhand, T.; Rueda, C.; Serrano, E.; Diamond, B.; Hassoun, H.; Mailankody, S.; Shah, U. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes of limited stage high grade B-cell lymphoma with MYC/BCL2 and/or BCL6 rearrangements: A single center experience
    Meeting Abstract

    Lue, J. K.; Luttwak, E.; Caron, P.; Boardman, A. P.; David, K. A.; Rivas-Delgado, A.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; Hamlin, P. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Revealing novel mechanisms underlying inactivation of tumor suppressor genes on duplicated chromosomes in multiple myeloma
    Meeting Abstract

    Cirrincione, A.; Kaddoura, M.; Poos, A. M.; Ziccheddu, B.; Maclachlan, K. H.; Chojnacka, M.; Diamond, B.; Blaney, P.; Gagler, D.; Zhang, Y.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Clinical outcomes associated with del(17p) in newly diagnosed multiple myeloma treated with triplet and daratumumab-based quadruplet induction regimens
    Meeting Abstract

    Jurgens, E.; Firestone, R.; Maclachlan, K. H.; Nemirovsky, D.; Derkach, A.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U. A.; Rajeeve, S.; more...
    Blood (2023)

    Fulltext@MSK | Save